Tasly Pharmaceuticals, Inc. (TaslyUS), was founded in 2006 and is based in Rockville, Maryland.

At Tasly our vision is to change the way the world takes and understands medicine. Through decades of research and development, we are geared to become a world-renowned innovator in pharmaceuticals, biologics, and nutraceuticals.

Our efforts have also been recognized as T89 (Dantonic) has become the first herbal medicine derived compound to complete an FDA Phase III global clinical trial with promising data. The results indicated that T89’s pharmacological functionalities in improving blood circulation, boosting energy metabolism level, and reducing blood thickness made the drug to express clinically significant benefits.